Birdsgrove House closes to avoid further waste of charitable funds
Birdsgrove House, the Royal Pharmaceutical Society’s convalescent home since 1946, is to close with immediate effect to avoid further wastage of Benevolent Fund resources.
In future, pharmacists who need help with convalescence, rest and recuperation
will be offered other facilities to meet their needs — in their
own areas where possible. Members in need of addiction treatment will
be supported through referral to other specialist service providers.
Over the past five years, the charity has incurred a deficit of £1.8m
in the cost of running the house and its services. In addition, a capital
investment of at least £500,000 is needed to upgrade the house
if it is to meet the requirements of the Disability Discrimination Act
1995 and recent legislation controlling the provision of care services.
This estimate has recently been increased from a provisional figure of £350,000
(PJ, 4 June, p686).
The trustees of the Benevolent Fund, who are the 30 members of the Society’s
Council, made the closure decision at a meeting on 3 August after considering
an independent feasibility study and a range of options.
The trustees agreed that continuing to maintain Birdsgrove House would
be detrimental to the need to safeguard the financial future of the Benevolent
Fund while developing and expanding the range of support services offered
to pharmacists. They also noted that the Charities Commission would be
unlikely to allow such a drain on the fund’s resources to continue
for much longer.
The trustees decided that the best way forward will be to close all facilities
at Birdsgrove House and to investigate the best way of realising the
value of the property for the benefit of the charity.
Among the factors taken into account in the trustees’ decision
are the following:
· The use of the convalescence facilities has steadily declined over
the years, despite efforts to reverse the trend, and there is no realistic
expectation of an upturn
· New regulations make it impossible for the house to continue in its
dual role as both a rest and recuperation centre and an addiction treatment
centre
· Neither of the services provided by
the house could continue independently without incurring considerable
capital expenditure
· The rest and recuperation service could never generate enough income
to cover its costs
The rest and recuperation service has been suspended for the past year
following advice from the National Care Standards Commission (whose role
has now moved to the new Healthcare Commission) that the dual
use of the house had to cease immediately (PJ, 14 May, p596). Since the suspension,
members in need of rest and recuperation have been offered alternative
support. The Benevolent Fund says that in many cases the alternative
service better meets the need because it is available in the pharmacist’s
own locality.
The last patient at the addiction treatment centre was due to complete
treatment this week. In future, members in need of addiction treatment
will be supported through referral to other specialist service providers.
The aftercare service for past clients of the Birdsgrove House service
will continue.
The sale of the property is subject to Charity Commission approval, which
could take severl months to obtain. The trustees agreed that, subject
to the commission’s agreement, the property should be disposed
of in a way that would provide the maximum return to the Benevolent Fund.
The value of the property is estimated at about £1.7m. If a buyer
or buyers cannot be found, the property may be offered for lease.
Over the years many individuals and a number of Society branches and
other organisations have made donations to the house, usually as gifts
of money but in many cases as gifts of furniture, works of art, etc.
Where possible, the trustees will consult the donors about the disposal
of these assets.
Closing the house will mean redundancies among the staff, who number
more than 30, full-time, part-time and casual. On 6 August, the Society’s
director of finance and resources, Bernard Kelly, and the head of human
resources, Vivienne Murch, visited the house to inform staff of the decision
personally. Over the next few weeks, individual and joint consultation
meetings will be held with staff to discuss the best way of implementing
the decision.
News feature, p220
Benevolent Fund
The Royal Pharmaceutical Society’s Benevolent
Fund provides help to distressed members or former members, their
widows, orphans or other dependents, and students registered with
the Society.
The fund is always in need of donations to support its work. Donations
may be sent to the Benevolent Fund, Royal Pharmaceutical Society,
1 Lambeth High Street, London SE1 7JN.
Some of the areas of support offered by or through the Benevolent
Fund are outlined below. Unless otherwise stated, further information
is available from the Benevolent Fund co-ordinator, Beverly Nicol
(tel 01323 890135).
Convalescence The Benevolent Fund continues
to support those in need of convalescence or rest and recovery.
Referral can be made
to services suited to the individual’s own needs and geographical
location.
Stress counselling The Benevolent Fund finances the Listening
Friends Scheme, which provides an opportunity to discuss problems
in confidence with a fellow pharmacist trained in listening skills.
The service can be accessed by telephoning its help-line on 020
7572 2442.
Addiction treatment The Benevolent Fund provides
support for the Pharmacists’ Health Support Programme,
an independent service for pharmacists who experience problems
with alcohol or other drugs
of addiction, or who have other problems that impair their fitness
to practise. Help can be obtained by telephoning a helpline (tel
01926 315138).
Financial assistance Financial assistance can be provided for
those in genuine need. It may take the form of regular grants,
one-off payments ir interest-free loans.
Welfare advice The Benevolent Fund offers advice on a wide range
of welfare issues. |
|